Vysis® UroVysion for the detection of urothelial carcinoma

被引：78
|
作者：
Halling, KC [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Lab Genet, Rochester, MN 55905 USA
来源：
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | 2003年 / 3卷 / 04期
基金：
美国国家科学基金会;
关键词：
bladder cancer; bladder tumor markers; FISH; urine cytology; urothelial carcinoma; Vysis (R) UroVysion;
D O I：
10.1586/14737159.3.4.507
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
For decades, cystoscopy and urine cytology have been the mainstay for monitoring superficial urothelial carcinoma patients for tumor recurrence. However, urine cytology has poor sensitivity for urothelial carcinoma and, consequently, numerous investigators have been endeavoring to develop more sensitive assays for the detection of urothelial carcinoma. This article presents an overview of the types of new assays that have been developed for urothelial carcinoma detection but focuses primarily on the features and performance of a new fluorescence in situ hybridization assay for urothelial carcinoma detection known as Vysis(R) UroVysion.
引用
收藏
页码：507 / 519
页数：13
相关论文
共 50 条
  • [31] Urinary mRNA biomarker panel for the detection of urothelial carcinoma
    Urquidi, Virginia
    Netherton, Mandy
    Gomes-Giacoia, Evan
    Serie, Daniel
    Eckel-Passow, Jeanette
    Rosser, Charles J.
    Goodison, Steve
    ONCOTARGET, 2016, 7 (25) : 38731 - 38740
  • [32] Atezolizumab in urothelial bladder carcinoma
    Hamilou, Zineb
    Lavaud, Pernelle
    Loriot, Yohann
    FUTURE ONCOLOGY, 2018, 14 (04) : 331 - 341
  • [33] Proteome research in urothelial carcinoma
    Kageyama, Susumu
    Isono, Takahiro
    Iwaki, Hideaki
    Hanada, Eiki
    Tomita, Keiji
    Yoshida, Tetsuya
    Yoshiki, Tatsuhiro
    Kawauchi, Akihiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (07) : 621 - 628
  • [34] DNA methylation in urothelial carcinoma
    Schulz, Wolfgang A.
    Goering, Wolfgang
    EPIGENOMICS, 2016, 8 (10) : 1415 - 1428
  • [35] Analytical Validation of Cxbladder® Detect, Triage, and Monitor: Assays for Detection and Management of Urothelial Carcinoma
    Harvey, Justin C.
    Cambridge, Lisa M.
    Ellen, Charles W.
    Colonval, Megan
    Hazlett, Jody A.
    Newell, Jordan
    Zhou, Xin
    Guilford, Parry J.
    DIAGNOSTICS, 2024, 14 (18)
  • [36] ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens
    Moatamed, Neda A.
    Rao, Jian-Yu
    Alexanian, Serge
    Cobarrubias, Melissa
    Levin, Mary
    Lu, David
    Apple, Sophia K.
    CANCER CYTOPATHOLOGY, 2013, 121 (06) : 320 - 328
  • [37] Emerging drugs for urothelial carcinoma
    Gartrell, Benjamin A.
    Sonpavde, Guru
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (04) : 477 - 494
  • [38] p16INK4a Expression Analysis as an Ancillary Tool for Cytologic Diagnosis of Urothelial Carcinoma
    Nakazawa, Kumiko
    Murata, Shin-ichi
    Yuminamochi, Tsutomu
    Ishii, Yoshio
    Ohno, Shikine
    Nakazawa, Tadao
    Kondo, Tetsuo
    Katoh, Ryohei
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 776 - 784
  • [39] Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma
    Loghin, Andrada
    Chibelean, Calin
    Orsolya, Martha
    Nechifor-Boila, Adela
    Nechifor-Boila, Alin
    Borda, Angela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2014, 55 (03) : 939 - 945
  • [40] Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma
    Lin, Tianhai
    Liu, Zhenhua
    Lu, Liangren
    Yang, Lu
    Han, Ping
    Zhang, Peng
    Wei, Qiang
    ONCOLOGY LETTERS, 2017, 13 (05) : 3928 - 3934
12345